Chugai Pharmaceutical : Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
April 26, 2024 at 10:36 am EDT
Share
April 26, 2024
Name of listed company: Chugai Pharmaceutical Co., Ltd.
Code number:
4519 (Prime Market of Tokyo Stock Exchange)
Head office:
1-1,Nihonbashi-Muromachi2-Chome,Chuo-ku, Tokyo
President & CEO:
Osamu Okuda
Inquiries to:
Kae Miyata
Head of Corporate Communications Dept.
Tel: +81-(0)3-3273-0554
Notice of Completion of Disposal of Treasury Shares as Restricted
Stock Compensation Plan
TOKYO, April 26, 2024--Chugai Pharmaceutical Co., Ltd.announced that disposal of treasury shares was completed today, as we announced in the press release "Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan" on March 28, 2024. The result of treasury shares is as follows.
1. Overview of Disposal
(1)
Disposal date
April 26, 2024
(2)
Class and number of disposed shares
100,200 shares of Common stock of the Company
(3)
Disposal price
¥5,927 per share
(4)
Total value of disposed shares
¥593,885,400
(5)
Allottees and number thereof;
Directors
3
38,800 shares
number of disposed shares
Vice presidents
11
22,000 shares
Employees
105
35,500 shares
Director of subsidiaries
4
1,200 shares
Employees of subsidiaries 9
2,700 shares
###
Attachments
Original Link
Original Document
Permalink
Disclaimer
Chugai Pharmaceutical Co. Ltd. published this content on
26 April 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
26 April 2024 14:36:31 UTC.
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).